FDA Drug Approval, N016466, ARISTOSPAN
FDA Drug Approval, N016466, ARISTOSPAN
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 016466
Company: SANDOZ
Drug Name: ARISTOSPAN
Active Ingredients: TRIAMCINOLONE HEXACETONIDE
Strength: 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/29/1969
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Company: SANDOZ
Drug Name: ARISTOSPAN
Active Ingredients: TRIAMCINOLONE HEXACETONIDE
Strength: 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/29/1969
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details